Featured Research

from universities, journals, and other organizations

Urgent need for multifactorial interventions to treat diabetes mellitus

Date:
June 3, 2014
Source:
Florida Atlantic University
Summary:
World renowned researchers emphasize the critical need for clinicians to aggressively utilize a multi-pronged approach to reducing the risk of complications and premature death from type 2 diabetes mellitus. Clinicians should consider adopting all approaches of proven benefit in screening and managing their patients, which include adjunctive drug therapies to therapeutic lifestyle changes to achieve sustained weight loss, increases in physical activity, lipid, blood pressure and glycemic control.

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions." These researchers emphasize the critical need for clinicians to aggressively utilize a multi-pronged approach to reducing the risk of complications and premature death from type 2 diabetes mellitus.

Related Articles


"There is an emerging pandemic of type 2 diabetes that is related to the dramatic increase in obesity, fast becoming the leading avoidable cause of death worldwide," said Hennekens. "People with type 2 diabetes have twice the risk for premature death due to complications from kidney failure, stroke, heart failure, and blindness due to retinopathy."

The authors state that intensive glucose control -- a cornerstone of treatment for patients with diabetes -- is necessary, but not sufficient to achieve the maximum benefits in reducing complications and premature death. Clinicians should consider adopting all approaches of proven benefit in screening and managing their patients, which include adjunctive drug therapies to therapeutic lifestyle changes to achieve sustained weight loss, increases in physical activity, lipid, blood pressure and glycemic control.

According to National Center of Health Statistics data from a random sample of the U.S. population aged 20 years and older, 20 percent have metabolic syndrome -- a constellation of high blood pressure, obesity, insulin resistance, and high cholesterol. In those 50 years or older, 40 percent have metabolic syndrome, and their 10-year risk for a first coronary event is 16 to 18 percent.

The authors advise that evidence-based doses of statins, aspirin, ACE inhibitors or ARBs should be prescribed as adjuncts to therapeutic lifestyle changes in the aggressive management of diabetes.

"The adoption of therapeutic lifestyle changes, which include weight loss and increased physical activity would preclude the need for pharmacologic interventions for most people with type 2 diabetes," said Hennekens. "Unfortunately, in the U.S., many patients prefer the prescription of pills to the prescription of a healthier lifestyle."

U.S. adolescents today are already heavier, less physically active, smoke more, and have already developed type 2 diabetes at a higher rate than their parents' generation did in their adolescence. Thus, they may become the first U.S. generation since 1950 to have higher rates of cardiovascular disease than their parents.

From a clinical and public health perspective, the authors also express their concern on the alarming findings regarding the under-treatment of type 2 diabetes in sub-populations in the U.S. such as the mentally ill as well as in many countries worldwide. They provide best practices guidelines for blood pressure and cholesterol screenings, while urging clinicians and policy makers to implement multifactorial interventions.

It is estimated that if present trends in obesity and physical inactivity continue, it is likely that one-third of U.S. adults will have diabetes by 2050.


Story Source:

The above story is based on materials provided by Florida Atlantic University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Charles H. Hennekens, MD; Marc A. Pfeffer, MD; John W. Newcomer, MD; Paul S. Jellinger, MD, MACE; and Alan Garber, MD, PhD. Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions. American Journal of Managed Care, May 2014

Cite This Page:

Florida Atlantic University. "Urgent need for multifactorial interventions to treat diabetes mellitus." ScienceDaily. ScienceDaily, 3 June 2014. <www.sciencedaily.com/releases/2014/06/140603091958.htm>.
Florida Atlantic University. (2014, June 3). Urgent need for multifactorial interventions to treat diabetes mellitus. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/06/140603091958.htm
Florida Atlantic University. "Urgent need for multifactorial interventions to treat diabetes mellitus." ScienceDaily. www.sciencedaily.com/releases/2014/06/140603091958.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins